Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 1 relevant journal, 4 Conferences, 94 Workshops are presently dedicated exclusively to reproduction and about 40 open access articles are being published on reproduction.
Generation or reproduction is the natural process by which new "posterity" singular creatures are created from their "guardians". Generation is a key gimmick of all known life; every individual creature exists as the consequence of multiplication. The known routines for propagation are comprehensively gathered into two principle sorts: sexual and agamic.
In abiogenetic generation, an individual can duplicate without inclusion with an alternate individual of that species. The division of a bacterial cell into two little girl cells is a case of abiogenetic propagation. Agamic propagation is not, on the other hand, restricted to single-celled organic entities. Most plants can imitate agamically and the burrowing little creature species Mycocepurus smithii is thought to recreate altogether by abiogenetic means.
Sexual proliferation ordinarily requires the inclusion of two people or gametes, one each from inverse kind of sex. The spread of living beings can additionally happen through cloning.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope & Importance:
Reproduction Conferences provide platform to explore extensive variety of regenerative systems utilized by diverse species. A few creatures, for example, the human and Northern Gannet, don't arrive at sexual development for a long time after conception and that being said produce few posterity. Others imitate rapidly; at the same time, under ordinary circumstances, most posterity doesn’t get by to adulthood. Case in point, a rabbit (develop following 8 months) can create 10–30 posterity for every year, and a tree grown foods fly (develop following 10–14 days) can deliver up to 900 posterity for every year. These two primary methodologies are known as K-determination (little posterity) and r-choice (numerous posterity). Reproduction Conferences discuss which technique is supported by development relies on upon an assortment of circumstances. Creatures with little posterity can give more assets to the sustaining and security of every individual posterity, subsequently decreasing the requirement for some posterity. Then again, creatures with numerous posterity may dedicate fewer assets to every individual posterity; for these sorts of creatures it is basic for some posterity to pass on not long after conception, yet enough people normally get by to keep up the populace.
According to a new market report published by Transparency Market Research "Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Share, Growth, Trends and Forecast, 2013 - 2019," the global market for human reproductive technologies was valued at USD 23.0 billion in 2012 and is expected to reach USD 27.1 billion in 2019, growing at a CAGR of 2.2% from 2013 to 2019.
Human reproductive technologies include procedures and therapies for conceiving or controlling pregnancy by means of artificial and/or semi artificial medical solutions. Lack of awareness about the reproductive deficiencies and their treatment necessity and availability has been limiting the market to explore its potential value. Therefore, awareness strategies adopted by market players with proper guidance for patients will fuel the emerging human reproductive technologies market especially the infertility treatment market. Developing regions such as the Asia-Pacific, Latin America, Africa and Middle-East hold the maximum growth potential in the human reproductive technologies market. Some of the other factors contributing to the growth of human reproductive technologies market include delay in conceiving, lifestyle habits such as smoking, excessive alcohol consumption, increasing use of contraceptive pills and devices, and rising incidences of infertility.
The infertility treatment market is characterized by the presence of many leading patented drug brands which are restraining the entry of generics and hence, creating a monopolistic situation. In addition, due to patient sentiments attached to infertility treatment procedures, risk ofno conception due to a low-quality generic drugis usually avoided. This report includes market analysis for seven major (by sales) branded formulations of infertility drugs, namely, Gonal-f, Follistim AQ, AndroGel, Testim, Viagra, Cialis and Levitra/Staxyn. Similarly, the contraceptive drugs and devices market has many drugs in the research pipeline awaiting commercialization to grab a share of this potential market. Large and well established pharmaceutical players such as Merck Serono, Merck & Co., Inc., Bayer AG, Pfizer, Inc., Actavis plc, Ferring International Center S.A. and Teva Pharmaceutical Industries Ltd. dominate the human reproductive technologies market.
The global contraceptives market was valued at USD 16.0billion in 2012 and is expected to grow at a CAGR of 5.5% from 2013 to 2019. The oral contraceptive pills market lead the overall contraceptives market in 2012 in terms of revenue, mainly due to increasing population awareness through advertisements enabling patients to buy them over-the-counter. In the contraceptive devices market, male condoms formed the largest market segment owing to the increased accessibility and awareness along with their ease of use.
3. Polycystic Ovarian Syndrome Conference
November 16-18, 2015 Seattle, USA
4. 2nd Polycystic Ovarian Syndrome Congress
October 06-08, 2016 Miami, USA
5. Translating Basic Science into Clinical Applications
6. Society for Reproduction and Fertility (SRF) Meeting
7. Mammalian Reproduction - Translating Basic Science into Clinical Applications
8. Satellite meeting of the World Congress of Reproductive Biology
9. 23rd Annual Postgraduate Course in Advanced Gynaecologic Surgery
Relevant Societies and Associations:
1. Society for the Study of Reproduction (SSR)
2. Society for Reproduction and Fertility
3. Society for Reproductive Biology
4. Polycystic Ovarian Syndrome Awereness Association(PCOSAA), Seattle, USA
5. Awareness AssociationAwareness Association, Seattle, USA
6. Seattle Reproductive Medicine Association, Seattle, USA
7. Pacific Gynecology Association, Seattle, USA
8. Androgen Excess and Polycystic Ovary Syndrome(AE-PCOS)Society, USA
9. Endocrine Society (USA)
10. American Dietetic Association, USA
11. American Society Reproductive Medicine, USA
12. American Association Of Clinical Endocrinologists, USA
13. The European Society of Human Reproduction and Embryology
14. Australian Breastfeeding Association
15. Polycystic Ovary Syndrome Association of Australia
16. The Association of UK Dietitians
17. Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association
1. Pregnitude, Seattle, USA
2. Seattle Natural Products Private Limited, Seattle, USA
3. CORCare, Seattle, USA
4. Medtronic, Seattle, USA
5. Conquer Your PCOS Naturally, USA
6. Glucorein, USA
7. PCOS Diva, USA
8. Progensa, USA
9. Inofolic, USA
10. Endotelon, USA
11. Duo fertility, USA
12. Branches, USA
13. Reproductive Fertility Nutritionals, USA
14. Akumentis, USA
15. PCOS Nutrition center, USA
16. Verity - The PCOS Self Help Group
17. Tanaka Bio Device
20. Nutri Health Care
21. Chiral Balance Women Wellness
22. Jidnyatix Life Sciences
This page will be updated regularly.
This page was last updated on August 4, 2020